black hole puts credibility on the line !!

It?s been tough times in the market and no stock has done that well, but even in this environment the lack of updates on the progress at PYC is starting to look bad. As a result management credibility and PYC shareholders will suffer.

Nick Wolfe has consistently said three deals in 2011, but 9 months in we?re yet to see anything. If he can average 1 a month from here, great, but if he doesn?t he?s going to look like a goose. Better he fess up now than try to let it slide.

Then as Peace pointed out in his post on the 16th, still left out of the equation is news about -

>> Roche ? undisclosed -> STILL !!?
>> Phenomica
>> Internal candidates - CD40L & PYCAG5
>> Platform Technology / Peptide Libraries / IP
>> Recent bio-partners - Isogenica / Xl-Protein / Pepscan
>> Being cash flow positive this year ? the last 4C certainly didn?t look like it.

The only possible ?upside? to the silence may be if they?re working on a mega deal of sorts, a takeover or something. Anything is possible as we?re completely in the dark.

It?s clear that some on the forum have already started to lose confidence. If we don?t start getting something out soon, what will cornerstone investors start thinking?

Notwithstanding poor market conditions management have to start hitting some milestones and improving communication, otherwise it could be a lean xmas for PYC holders.